The Brief
Mar. 18, 2015

Shared decision making in cancer
Oncology Nurse Advisor
As oncology nurse navigators, we often are faced with helping patients and families make tough decisions about cancer treatment. In my own practice with prostate cancer, there can be several, seemingly equal, effective treatment options with no true standout. Given our expertise and experience with patients, oncology nurse navigators are in a prime position to help with decision making — not to give true medical advice, but perhaps to help patients and families arrive at a well-thought-out decision.More

Something's got to give: Paying for cancer care
Clinical Oncology
Physicians, patients, payors and politicians all want to see reform for the entire U.S. health care system, but nowhere is reform needed more than in the area of cancer care. The rising costs of cancer care today are unsustainable. In this series, Clinical Oncology News takes an in-depth look at the problem, as well as solutions that might help cure what ails health care in America.More

CDC: Cancer survival rates: 2 in 3 cancer patients survive 5 years or more; prostrate cancer has best survival rate of 97 percent
The Christian Times
Two of three people with cancer survive five years or more, according to a study by the Centers for Disease Control and Prevention (CDC). According to the CDC, the most common cancers are prostate cancer, which has about 128 cases per 100,000 men; female breast with 122 cases per 100,000 women; lung and bronchus with 61 cases per 100,000; and colon and rectum with 40 cases per 100,000.More

75 cancer programs earn the Outstanding Achievement Award
ACS
The Commission on Cancer (CoC), a Quality Program of the American College of Surgeons, has presented the 2014 Outstanding Achievement Award (OAA) to 75 CoC-accredited cancer programs in the U.S.

Established in 2004, the OAA recognizes cancer programs that demonstrate excellence by earning commendation for all applicable standards and providing quality care to patients with cancer. A program earns the OAA by completing the accreditation survey and receiving a Performance Report that indicates an accreditation award of "Three-Year with Commendation" outlining the commendation ratings for the seven commendation-level standards and no deficiencies. More

Intensive care gets friendlier with apps, devices
The Wall Street Journal
Hospitals are redesigning intensive care units (ICUs) to make them safer and less dehumanizing with a new focus on engaging families and patients in decisions. ICU teams are testing novel approaches to solicit input from patients and their families and to honor their preferences and goals for care. Many are using apps and devices to link up medical teams with families. Evidence has shown that patient and family participation can improve safety and outcomes, and hospitals are putting a failure to treat patients with respect and dignity on par with other preventable medical complications.More

Pursuing Excellence through NAPBC Accreditation approved for 6.5 CEs from NCRA

Plan now to join us on April 24 at the Westin Westminster Denver-Boulder Hotel for the National Accreditation Program for Breast Centers (NAPBC) Pursuing Excellence through NAPBC Accreditation workshop. Attending this program — taught by experienced NAPBC committee members, board members, surveyors and staff — will give you the knowledge to develop and operate a high-quality breast center and achieve and maintain NAPBC accreditation. Registration for this program is now open.More

New 'Recovery Room' episode available — The Essential Relationship Between Surgeon and Pathologist
ACS
In this episode of "The Recovery Room," host Dr. Frederick Greene, FACS, speaks to Dr. Carolyn Compton, an academic pathologist at Arizona State University, and Dr. Terry Sarantou, FACS, a surgical oncologist at the Levine Cancer Institute, about the surgeon-pathologist relationship, each from the respective fields of surgery and pathology. Listen to this episode.More

Northwest doctors are spot on when diagnosing breast cancer
Portland Business Journal
Pathologists — including those in Oregon — are doing a good job diagnosing invasive breast cancer, according to a study published today in JAMA. "Women who have cancer are getting some pretty accurate diagnoses," said Dr. Heidi Nelson, medical director of cancer prevention and screening at Providence Cancer Center, a professor at Oregon Health & Science University School of Medicine, and a co-investigator of the study.More

Potential drug target found to prevent bowel cancer spread
Medical Xpress
Monash scientists have discovered a molecule that is crucial to the survival of stem cells in the intestine. Importantly, the molecule plays a key role in bowel cancer — particularly its deadly ability to metastasise. The newly discovered molecule may act as an indicator of how aggressive colorectal cancer is and as a target for treatment aimed at preventing the bowel cancer from spreading.More

Register now for the NCDB Workshop and Survey Savvy

The National Cancer Data Base (NCDB) Workshop and Survey Savvy will be held in Chicago June 17-19. The NCDB Workshop, Maximizing NCDB Data to Improve Your Cancer Program, will review the current uses and future updates for the NCDB quality tools. Major NCDB quality tools will be reviewed with a focus on how the data can be used to inform decisions for cancer program administration and by cancer physicians. Learn about the uses for the cancer registry and how patient navigators can use the data.

Survey Savvy provides in-depth review of the information your cancer committee needs to coordinate a high-quality, patient-centered, multidisciplinary cancer program. Developed by Commission on Cancer (CoC) staff and CoC committee leadership, this program addresses your cancer program's most common questions, issues and concerns regarding CoC standards and compliance.

Whether your cancer program is preparing for a re-accreditation survey or looking for clarification on the standards, this program provides increased understanding of standard requirements and implementation. Through lectures, panel presentations and the opportunity to meet and speak with experts, cancer program members will learn how to use the CoC standards as a framework to develop a comprehensive cancer care program that delivers high-quality and patient-centered care. Plan now to attend these meetings.More

Current and future applications of genetic prostate cancer screening in the urologic clinic
Medscape
The limitations of PSA and DRE screening for prostate cancer have prompted much research into genetic-based screenings. This survey of innovations and obstacles in genomic testing will help prepare urologic clinicians for future interventions.More

No more unnecessary biopsies? Provista gets $3.9 million for proteomic breast cancer tests
MedCity News
Without a biopsy, it's difficult to determine whether a woman has breast cancer. But biopsies are costly and invasive, and often — in women with fibrous breast tissue and no cancer — they're actually unnecessary. Scottsdale start-up Provista Diagnostics is developing a way to help diagnose women's cancers more accurately — with just the use of a proteomics-based assay and standard imaging.More

Inappropriate breast, prostate cancer imaging 'may be driven by
regional factors'

Medical News Today
A new study published in JAMA Oncology has identified a regional-level link between inappropriate low-risk prostate cancer and breast cancer imaging, which suggests the presence of certain regional factors that may be driving this association.More

Dietary dioxins not associated with increased breast cancer risk
Medical Xpress
Estimated exposure to dioxins through dietary intake is not associated with an increased risk of developing breast cancer among low-exposed women, according to a large cohort study published in the open access journal Breast Cancer Research. This finding contradicts a popular belief held by many about the effect of dioxins.More